1. Home
  2. CRM vs AMGN Comparison

CRM vs AMGN Comparison

Compare CRM & AMGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Salesforce Inc.

CRM

Salesforce Inc.

HOLD

Current Price

$229.79

Market Cap

248.2B

Sector

Technology

ML Signal

HOLD

Logo Amgen Inc.

AMGN

Amgen Inc.

HOLD

Current Price

$328.78

Market Cap

181.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRM
AMGN
Founded
1999
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.2B
181.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CRM
AMGN
Price
$229.79
$328.78
Analyst Decision
Buy
Hold
Analyst Count
35
14
Target Price
$324.12
$321.69
AVG Volume (30 Days)
6.6M
2.7M
Earning Date
02-25-2026
02-03-2026
Dividend Yield
0.71%
3.05%
EPS Growth
23.36
65.12
EPS
7.49
12.93
Revenue
$40,317,000,000.00
$35,971,000,000.00
Revenue This Year
$10.58
$10.82
Revenue Next Year
$11.08
$1.73
P/E Ratio
$31.18
$25.52
Revenue Growth
8.41
10.56
52 Week Low
$221.96
$261.43
52 Week High
$367.09
$346.38

Technical Indicators

Market Signals
Indicator
CRM
AMGN
Relative Strength Index (RSI) 28.86 51.08
Support Level $252.31 $319.79
Resistance Level $261.56 $332.50
Average True Range (ATR) 6.95 7.08
MACD -4.27 -0.22
Stochastic Oscillator 7.85 44.14

Price Performance

Historical Comparison
CRM
AMGN

About CRM Salesforce Inc.

Salesforce provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.

About AMGN Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Share on Social Networks: